RBL001/RBL002
/ BioNTech
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
January 15, 2020
IVAC MUTANOME Phase I Clinical Trial
(clinicaltrials.gov)
- P1; N=15; Completed; Sponsor: Biontech RNA Pharmaceuticals GmbH; Active, not recruiting ➔ Completed
Clinical • Trial completion
August 05, 2019
IVAC MUTANOME Phase I Clinical Trial
(clinicaltrials.gov)
- P1; N=15; Active, not recruiting; Sponsor: Biontech RNA Pharmaceuticals GmbH; Trial completion date: Mar 2019 ➔ Oct 2019
Clinical • Trial completion date
1 to 2
Of
2
Go to page
1